Morris Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,550
| Closed | -$2.12M | – | 61 |
|
|
2020
Q4 | $2.12M | Sell |
13,550
-1,027
| -7% | -$160K | 1.74% | 26 |
|
|
2020
Q3 | $1.67M | Sell |
14,577
-1,193
| -8% | -$137K | 1.47% | 26 |
|
|
2020
Q2 | $1.77M | Sell |
15,770
-592
| -4% | -$66.4K | 1.6% | 25 |
|
|
2020
Q1 | $1.47M | Buy |
16,362
+7,322
| +81% | +$657K | 1.57% | 25 |
|
|
2019
Q4 | $978K | Sell |
9,040
-9,838
| -52% | -$1.06M | 0.82% | 30 |
|
|
2019
Q3 | $1.85M | Sell |
18,878
-747
| -4% | -$73.2K | 1.62% | 29 |
|
|
2019
Q2 | $2.57M | Sell |
19,625
-1,692
| -8% | -$222K | 2.14% | 19 |
|
|
2019
Q1 | $2.88M | Buy |
21,317
+4,803
| +29% | +$649K | 2.26% | 22 |
|
|
2018
Q4 | $1.61M | Sell |
16,514
-7,053
| -30% | -$687K | 1.37% | 30 |
|
|
2018
Q3 | $3.28M | Sell |
23,567
-98
| -0.4% | -$13.6K | 2.19% | 23 |
|
|
2018
Q2 | $2.94M | Buy |
23,665
+1,609
| +7% | +$200K | 2.06% | 27 |
|
|
2018
Q1 | $2.46M | Buy |
22,056
+1,872
| +9% | +$209K | 1.63% | 28 |
|
|
2017
Q4 | $2.41M | Buy |
+20,184
| New | +$2.41M | 1.58% | 29 |
|